Medical device company Globus Medical (NYSE:GMED) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On the other hand, the company ...

Globus Medical said the purchase would increase its portfolio of musculoskeletal technologies, therefore enhancing its position in neuromodulation and chronic pain management. Nevro, with its ...

AUDUBON, PA & REDWOOD CITY, CA — Globus Medical (NYSE: GMED) has announced a definitive agreement to acquire all shares of ...

Have you been paying attention to shares of Globus Medical (GMED)? Shares have been on the move with the stock up 7.3% over the past month. The stock hit a new 52-week high of $70.84 in the ...

Ratings for Globus Medical (NYSE:GMED) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their ...

Globus Medical’s initiative of offering robotics-driven surgical solutions is driving its long-term revenue growth. The company’s orthopedic trauma solutions enjoy strong demand in the ...

Medical device company Globus Medical (NYSE:GMED) in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On the other hand, the company’s full-year revenue guidance of $2.85 ...